Skip to main content

Table 1 Technical validation cohort of healthy donors

From: An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity

Median age (range) in years

33 (21; 64)

Gender, N (%)

 Male

11 (24.4%)

 Female

34 (75.6%)

CMV serostatus, N (%)

 Positive

32 (71.1%)

 Negative

13 (28.9%)

Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us